Thursday, July 30, 2020 (HealthDay News)
A new study shows that there is a low level of awareness among American women of a type of lymphoma that may occur around breast implants.
Anaplastic lymphoma involving breast implants (BIA-ALCL) is an immune system cancer. It is estimated to occur in about 1 in 3,000 to 1 in 12,000 women with structural breast implants. Smooth surface implants are associated with lower rates.
More than 620 cases and at least 17 deaths from BIA-ALCL have been reported worldwide.
Of the 500 US women surveyed, about 1 in 7 said they had heard of BIA-ALCL. However, of the 12% of respondents who had implants, more than half knew about it.
After receiving the BIA-ALCL risk information, about 58% of respondents said they were still ready for reconstructed breast implants and 46% would be ready for cosmetic breast implants. But 36% said they would be less likely to transplant.
Two-thirds of implanted women "express some degree of interest" related to BIA-ALCL, and 35% said they "are seriously considering transplant removal."
There are no current recommendations for breast implant removal in women without implant-related symptoms. Symptoms of BIA-ALCL include swelling, mass or pain in the implant area, according to research published in the July issue. Cosmetic and Orthopedic Surgery.
Dr. Justin Sacks, leader of <a target = "_ blank" href = "https://www.medicinenet.com/plastic/article.htmlm" rel = "sub" …